Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEP005 in superficial basal cell carcinoma
NCT00108134Phase 2Completed
- Sponsor
- Peplin
- Start
- Mar 2005
- Primary completion
- Mar 2006
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ingenol mebutate in basal cell carcinoma (BCC), sponsored by Peplin. Started Mar 2005; status: completed.
02
Drugs
ingenol mebutate
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on NCT00108134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00108134.